NuBloom Tirzepatide Review: Cost, a Corrected LegitScript Finding & Honest Verdict (2026)

This review's most important finding: NuBloom does display its own genuine LegitScript seal, served directly from LegitScript's own CDN, correcting the ranking's claim that only its telehealth partner is certified. This review also confirmed a real, literal drafting error live in NuBloom's own Terms. Every fact here comes from the company's own published program.

A corrected LegitScript finding

This review checked NuBloom's LegitScript status directly and found the ranking's claim was stale: the site displays a genuine LegitScript seal for mynubloom.com itself, served from static.legitscript.com/seals/45021264.png — LegitScript's own CDN — with a checker link explicitly naming "www.mynubloom.com,". This is NuBloom's own certification, not just its telehealth partner's.

A literal unfilled placeholder in the Terms

This review also confirmed directly, live on NuBloom's own Terms page: the governing-law clause names an unfilled "[STATE]" placeholder rather than an actual state — a real drafting error left live in a legal document, not a hypothetical.

What NuBloom is

NuBloom is a women's metabolic-health telehealth practice, founded and medically led by Dr. Marianne Pinkston Mueller, a family and integrative-medicine physician with 25+ years of experience. It pairs GLP-1s with hormone, gut-health, and longevity care plus in-depth lab testing.

What NuBloom costs

Compounded semaglutide runs $149/month and tirzepatide $279/month as flexible month-to-month subscriptions, with an optional 90-day 1:1 coaching program ($599/month) offering weekly meetings and unlimited text support.

The brand-vs-compounded question

NuBloom dispenses compounded tirzepatide, not the FDA-approved branded product — though the ranking flagged that one FAQ on the site loosely uses "FDA-approved" language that contradicts the correct disclaimers on the product pages themselves; this review's own homepage check found the product-page language correctly describes compounded drugs as not FDA-approved. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

NuBloom's real strengths: a genuinely verified LegitScript seal, and correcting a stale roster claim, plus openly published pricing, a named, credentialed physician, a whole-person care model, and 49-state coverage. The trade-offs, confirmed and is an unfilled "[STATE]" placeholder live in the Terms' governing-law clause, a compounding pharmacy that isn't named, all sales are final with no returns on prescription products, and disputes go to binding individual arbitration. As with any GLP-1 program, read the Terms closely given the drafting gap this review found; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NuBloom's LegitScript certification is genuinely stronger than previously documented — this review confirmed its own seal, not just a partner's — and its named, credentialed physician and whole-person model are real positives. The unfilled "[STATE]" placeholder in its Terms is a minor but real drafting error worth noting before you sign. For a similarly women-focused, physician-led provider, compare it against Nalena or Mevo Health. See our best tirzepatide providers ranking for the full field.